News Senior Republican hits out at Trump's research funding cuts The Republican chair of the Appropriations Committee has slammed the Trump administration for actions that are putting US biomedical research at risk.
News NEJM responds to claims of bias from Justice Department The New England Journal of Medicine (NEJM) has hit back at assertions of bias in its editorial policies from Republican activist Edward Martin Jr.
News Tariffs 'could cancel out discounts with biosimilars' Tariffs on US pharma imports could remove discounts offered to health systems by biosimilars and threaten the future of the sector, says a non-profit.
News Trump pledges drug price cuts – and action on 'pill penalty' A Trump executive order aimed at lowering drug prices includes a plan to do away with what industry claims is a flaw in the Inflation Reduction Act.
News US starts the clock ticking on pharma tariffs The US has launched a national security probe into the national security implications of importing pharmaceuticals, seen as a precursor to tariffs.
News US government appeals after judge blocks NIH funding cap HHS has said it plans to appeal a permanent injunction on big cuts to indirect funding for medical research awarded by the NIH.
News Senju launches first-in-class dry eye disease drug in Japan Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.